Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or North Dakota for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to North Dakota only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. North Dakota (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Anil Potti (NPI 1427122266)

Field	Value
Entity Type	Individual
Organization	Anil Potti
Address	1451 44th Ave S Ste E
City	Grand Forks
State	ND
ZIP	58201
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	November 20, 2006

Payer Source	Total Paid
Medicare	$4.9M
Medicaid	$0

Key Findings

This provider’s Medicare business is the clear revenue engine: Total Medicare revenue is $4.9M and there is no Medicaid billing on file, so the practice is effectively single‑payer (Medicare) in scale. The NPI was enumerated 2006-11-20 (~20 years ago), indicating a long-tenured Medicare billing history that likely supports an established outpatient oncology operation.

Revenue is highly concentrated in a small set of oncology biologics: the precomputed top 3 Medicare codes (J9271, J9299, J0897) account for 61.0% of this provider’s total Medicare revenue. Those three codes individually contributed $1.5M (J9271, 30.6%), $1.1M (J9299, 22.8%), and $367.2K (J0897, 7.6%) to the $4.9M Medicare total, signaling dependence on a handful of high-cost injectable therapies.

The procedural and drug mix points to an outpatient oncology infusion center model: large volumes of J9271 and J9299 (pembrolizumab and nivolumab) combined with chemotherapy administration codes such as 96413 and multiple infusion/IV push codes indicate the practice delivers systemic cancer therapy and supportive infusions on-site. High claim counts for infusion administrations and related supply codes suggest throughput and chair-time are core operational drivers rather than predominantly consult-only practice.

On competitive standing for key therapies, this provider ranks well above peers nationally: J9271 ranks #71 of 1841 providers nationally (96th percentile; notably above typical national volume for this code) and J9299 ranks #21 of 505 providers nationally (96th percentile; notably above typical national volume for this code). Even J0897 ranks #279 of 10057 providers nationally (97th percentile; notably above typical national volume for this code), which together indicate major national-level participation in these agents relative to most providers.

Multiple specific codes are statistical outliers in national volume, highlighting unusually high throughput in certain infusions and office visits. Notably, J1439 ranks #6 of 1209 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code), Q5118 ranks #2 of 161 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code), 99213 ranks #355 of 457151 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code), and 96372 ranks #44 of 58224 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code).

High E/M volume supports the picture of an active clinic managing ongoing therapy: 99213 appears 2.6K claims ($65 avg paid/claim, $168.5K revenue) and 99214 appears 1.6K claims ($99 avg paid/claim, $159.5K revenue), both described as extreme outliers or far above typical national volume. These elevated visit volumes combined with infusion billing imply frequent follow-up and management visits integral to the treatment workflow.

The provider shows notable adoption of biosimilars and supportive biologics alongside originator immunotherapies, which affects drug mix and purchasing patterns: Q5118 (bevacizumab-bvzr) generated $218K and ranks #2 of 161 providers nationally (99th percentile; extreme outlier), Q5115 (rituximab-abbs) contributed $164.6K and ranks #6 of 79 providers nationally (94th percentile; typical, unremarkable volume for this code), and Q5122 (pegfilgrastim-apgf) contributed $92.8K and ranks #14 of 239 providers nationally (95th percentile; typical, unremarkable volume). These patterns suggest both use of biosimilars and significant supportive care use in the practice.

Operationally and reimbursement-wise, the practice’s heavy reliance on a small number of high-revenue oncology injectables and very high infusion/administration volumes concentrates both revenue and operational exposure. With 61.0% of Medicare revenue tied to the top 3 codes and no Medicaid revenue to diversify payer mix, the provider’s revenue is sensitive to changes in Medicare coverage, reimbursement, or utilization patterns for those specific oncology agents.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

54 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	34,220	$40	$1.5M
J9299	Injection, nivolumab, 1 mg	45,640	$20	$1.1M
J0897	Injection, denosumab, 1 mg	20,400	$20	$367.2K
J1568	Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg	7,760	$30	$263.8K
J1439	Injection, ferric carboxymaltose, 1 mg	218,250	$1	$218.3K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	9,480	$20	$218K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	2,590	$70	$168.5K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	4,840	$30	$164.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,610	$100	$159.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	1,030	$100	$106.7K

Showing 1–10 of 54

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 54 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. North Dakota Distribution

Anil Potti — 15 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — North Dakota

Full comparison — all codes billed, vs. state median

54 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9299	1	10	45,640	$20	$1.1M
J9271	1	10	19,710	$40	$850.8K
J1568	1	10	7,760	$30	$260.9K
Q5118	1	10	9,480	$20	$221.6K
Q5115	1	10	4,840	$30	$163.8K
Q5122	1	10	1,020	$90	$92.4K
J1437	1	10	4,600	$20	$75.5K
Q5104	2	10	2,910	$30	$72.6K
J1439	1	10	24,750	$1	$61.8K
J0897	2	40	1,920	$20	$61.8K

Showing 1–10 of 54

Related Providers

Other providers that share a Tax Identification Number (TIN) with Anil Potti, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Marina Gilca	ND	Retina Specialist (Ophthalmology) Physician	$4.3M	$0
William Noyes	ND	Radiation Oncology Physician	$1.2M	$0
Darrin Johnson	MN	Diagnostic Radiology Physician	$908.4K	$0
Shree Subedi	WA	Diagnostic Radiology Physician	$774.2K	$0
Jonathan Marshall	NY	Diagnostic Radiology Physician	$761.9K	$4.4K
Towner County Medical Center Inc	ND	Rural Health Clinic/Center	$0	$763.3K
Christian Unity Hospital Corporation	ND	Rural Health Clinic/Center	$0	$736.8K
Matthew Manganaro	NY	Diagnostic Radiology Physician	$688K	$0
Myles Mitsunaga	CA	Diagnostic Radiology Physician	$510.8K	$113.9K
James Sullivan	MN	Diagnostic Radiology Physician	$589.8K	$0

Nearby Providers

Other providers in the same ZIP code as Anil Potti, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Development Homes Inc	ND	Community/Behavioral Health Agency	$0	$53.9M
Altru Health System	ND	Clinic/Center	$0	$29.7M
Altru Health System	ND	General Acute Care Hospital	$0	$18.7M
L.i.s.t.e.n. Inc	ND	Community/Behavioral Health Agency	$0	$9.4M
Peterson Medical Clinics, LLC	ND	Multi-Specialty Clinic/Center	$0	$8.8M
Edgewood Sartell LLC	ND	Assisted Living Facility	$0	$7.1M
Northeast Behavioral Health Clinic	ND	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$6.7M
Spectra Health	ND	Federally Qualified Health Center (FQHC)	$0	$5.5M
Little Miracles, Inc.	ND	Multi-Specialty Clinic/Center	$0	$5.5M
Valley Oral & Facial Surgery PC	ND	Oral and Maxillofacial Surgery Clinic/Center	$0	$4.5M

Anil Potti — Billing Profile & Reimbursement Data

Sign up for Anil Potti — Billing Profile & Reimbursement Data policy alerts

Anil Potti — Billing Profile & Reimbursement Data

Sign up for Anil Potti — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References